Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2018  |  Volume : 28  |  Issue : 1  |  Page : 54-58

Thrombolysis Followed by Apixaban for Massive Pulmonary Embolism and Free-floating Thrombus in Right Ventricle in a Patient with Breast Cancer


1 Department of Cardiology, Coronary Care Unit, G.F. Ingrassia Hospital Palermo, Italy
2 Emergency Room G.F. Ingrassia Hospital Palermo, Italy
3 Department of Chemistry, University of Palermo, Italy

Correspondence Address:
Dr. Sergio Fasullo
Department of Cardiology, Coronary Coronary Unit, Paolo Borsellino, Corso Calatafimi 1002, Palermo 90100
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jcecho.jcecho_35_17

Rights and Permissions

Free-floating thrombus in the right ventricle, associated with a massive acute pulmonary embolism (PE), is a rare phenomenon. PE is an important clinical entity with considerable mortality despite advances in diagnosis and treatment. The prognosis of PE depends on right ventricular dysfunction, myocardial injury markers, and early treatment. In this report, we present the case of a 71-year-old woman with a history of breast cancer admitted to intensive care unit for PE complicated by syncope. Although our case may seem complex because it is not represented in the guidelines, the result was satisfactory and showed how treatment with new anticoagulants (in this case apixaban) after massive thrombolysis of PE could be considered and included in the new guidelines.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1564    
    Printed28    
    Emailed0    
    PDF Downloaded89    
    Comments [Add]    

Recommend this journal